P-27 South American experience with a 3-week regimen of gemcitabine(GEM) and cisplatin (CIS) in advanced NSCLC: Preliminary results

R.L. Ramirez Gomez, Sergio Santillana, Sergio Poli et al.|Lung Cancer|2003

Cited by 0